Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 104Lung Neoplasms 44Breast Neoplasms 41Triple Negative Breast Neoplasms 33Ovarian Neoplasms 29Small Cell Lung Carcinoma 25Squamous Cell Carcinoma of Head and Neck 24Fallopian Tube Neoplasms 18Neoplasms 17Endometrial Neoplasms 17Uterine Cervical Neoplasms 13Neoplasm Metastasis 13Head and Neck Neoplasms 13Esophageal Squamous Cell Carcinoma 12Prostatic Neoplasms 10Parkinson Disease 4, Autosomal Dominant Lewy Body 10Esophageal Neoplasms 10Colorectal Neoplasms 10Carcinoma, Squamous Cell 9Recurrence 8Carcinoma, Transitional Cell 8Oropharyngeal Neoplasms 7Neuroblastoma 6Carcinoma, Ovarian Epithelial 6Urinary Bladder Neoplasms 5Mesothelioma 5Lymphoma, Large B-Cell, Diffuse 5Adenocarcinoma of Lung 5Stomach Neoplasms 4Pathologic Complete Response 4

Interventions

Injections 4tislelizumab 2Paclitaxel 2Cisplatin 2Capecitabine 2Bevacizumab 2Pemetrexed 1Oxaliplatin 1Gemcitabine 1Fluorouracil 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumour × Carboplatin × Clear all
NCT06783647 2026-05-18

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
230 enrolled
Other solid neoplasm

Advanced Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡